The "Mitral Valve Annuloplasty Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ...
Background: Accurately assessing the postoperative mortality and rehospitalization for heart failure risks in patients undergoing mitral valve repair surgery is of significant importance for ...
Highlighted text has been updated as of October 31, 2024. The MATTERHORN trial showed that M-TEER is noninferior to surgical mitral valve repair regarding clinical efficacy and has a better safety ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...